1. Protein Tyrosine Kinase/RTK Autophagy
  2. c-Met/HGFR Autophagy
  3. Tepotinib hydrochloride

Tepotinib hydrochloride  (Synonyms: EMD-1214063 hydrochloride)

目录号: HY-14721A
产品使用指南

Tepotinib (EMD-1214063) hydrochloride 是一种具有口服活性的、高度选择性,可逆的,ATP-竞争性的 c-Met 抑制剂,IC50 为 3 nM,对 c-Met 的选择性比 IRAK4,TrkA,Axl,IRAK1 和 Mer 高 200 倍以上。Tepotinib hydrochloride 抑制 c-Met 磷酸化,诱导自噬 (autophagy)。Tepotinib hydrochloride 具有抗肿瘤作用。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Tepotinib hydrochloride Chemical Structure

Tepotinib hydrochloride Chemical Structure

CAS No. : 1103508-80-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Tepotinib hydrochloride 的其他形式现货产品:

Customer Review

Other Forms of Tepotinib hydrochloride:

    Tepotinib hydrochloride purchased from MCE. Usage Cited in: Gene Expr. 2018 May 18;18(2):135-147.  [Abstract]

    Western blot for Myc-tag shows decrease in Myc-tag levels at 8 weeks of EMD1214063 treatment only. GAPDH shows comparable loading in all lanes.
    • 生物活性

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    Tepotinib (EMD-1214063) hydrochloride is an orally active and highly selective, reversible, ATP-competitive c-Met inhibitor with an IC50 of 3 nM, >200-fold selective for c-Met than IRAK4, TrkA, Axl, IRAK1, and Mer. Tepotinib hydrochloride inhibits c-Met phosphorylation and induces autophagy. Tepotinib hydrochloride has antitumor effects[1][2][3].

    体外研究
    (In Vitro)

    Tepotinib hydrochloride 抑制 IRAK4、TrkA、Axl、IRAK1、Mer 和 TrkA,IC50 分别为 615、1017、1566、2037、2272 和 5716 nM[1]
    Tepotinib hydrochloride 抑制 A549 细胞中
    HGF 诱导的 c-Met 磷酸化,平均 IC50 为 6 nM[1]
    Tepotinib (0.01 nM-30 μM) hydrochloride 可在体外抑制肿瘤细胞增殖和迁移[1]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    体内研究
    (In Vivo)

    Tepotinib hydrochloride 在异种移植模型中诱导肿瘤消退并抑制体内 c-Met 磷酸化[1]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: CD-1 or BALB/C nude mice bearing human cancer cell lines KP-4, or EBC-1[1]
    Dosage: 6 and 15 mg/kg for mice bearing NSCLC EBC-1; 25, 50 and 200 mg/kg for mice bearing pancreatic carcinoma cell line KP-4.
    Administration: Injected daily; for 14-18 days
    Result: Daily administration of 5 or 15 mg/kg to EBC-1 tumor-bearing mice resulted in effective inhibition or complete tumor regression, respectively.
    Induced dose-dependent tumor growth inhibition in mice bearing human pancreatic carcinoma KP-4 tumors.
    分子量

    492.57 (free base)

    Formula

    C29H28N6O2.xHCl

    CAS 号
    非同位 CAS

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    Please store the product under the recommended conditions in the Certificate of Analysis.

    纯度 & 产品资料
    参考文献

    Tepotinib hydrochloride 相关分类

    • 摩尔计算器

    • 稀释计算器

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量   浓度   体积   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称:

     

    * 需求量:

    * 客户姓名:

     

    * Email:

    * 电话:

     

    * 公司或机构名称:

       留言给我们:

    Bulk Inquiry

    Inquiry Information

    产品名称:
    Tepotinib hydrochloride
    目录号:
    HY-14721A
    需求量: